On April 29, 2025, the House Committee on Energy and Commerce held a full committee mark-up of six health care-related bills, including the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483). This bill includes language from the MATE Improvement Act (S.946), which designates the AGD as an approved provider of the mandatory continuing education for providers of certain controlled substances. The SUPPORT Act was reported out of committee by a vote of 36 – 13, advancing the bill to a future vote on the House floor. This marks a significant step in reauthorizing the SUPPORT Act and ensuring AGD's recognition in its continuing education provisions.

Impact on General Dentistry: While research indicates a decline in opioid prescriptions by dentists, they still account for approximately 8.6% of all opioid prescriptions nationwide. The AGD remains committed to educating general dentists on opioid addiction, responsible prescribing practices, and alternative approaches to pain management. AGD has continued to advocate for the passage of the SUPPORT Act.